Elliya Park

University of Toronto — Canada

Medicine · Health Sciences

4h-index74citations12works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(6), Nanoparticle-Based Drug Delivery(5), Neuroinflammation and Neurodegeneration Mechanisms(4), Nanoplatforms for cancer theranostics(3), Nerve injury and regeneration(2)

Publications12 total

Targeting Neuroinflammation by Bioreactive Nanoparticles for Early Detection and Intervention of Alzheimer’s Disease
Alzheimer s & Dementia·2025Open Access
A Novel Brain‐Penetrable Nanocarrier Delivers Brain‐derived Neurotrophic Factor for Treatment of Alzheimer’s Disease
Alzheimer s & Dementia·2025Open Access
A Novel Brain Penetrable Nanocarrier Delivers Brain‐Derived Neurotrophic Factor to Treat Alzheimer's Disease
Advanced Healthcare Materials·2025· 1 citedOpen Access
Mitigating radioresistance mechanisms by polymer-lipid manganese dioxide nanoparticles enhances immunogenic cell death and antitumor immune response to facilitate abscopal effect in breast tumor models
Drug Delivery and Translational Research·2025· 4 cited
Brain microenvironment-remodeling nanomedicine improves cerebral glucose metabolism, mitochondrial activity and synaptic function in a mouse model of Alzheimer's disease
Biomaterials·2025· 9 citedOpen Access
Evaluation of the biodistribution and preliminary safety profile of a novel brain-targeted manganese dioxide-based nanotheranostic system for Alzheimer’s disease
Nanotoxicology·2024· 2 cited
Biocompatible and bioactivable terpolymer-lipid-MnO2 Nanoparticle-based MRI contrast agent for improving tumor detection and delineation
Materials Today Bio·2024· 14 citedOpen Access
Brain Microenvironment-Remodeling Nanomedicine Improves Cerebral Glucose Metabolism, Mitochondrial Activity and Synaptic Function in a Mouse Model of Alzheimer's Disease
SSRN Electronic Journal·2024Open Access
Brain‐Penetrating and Disease Site‐Targeting Manganese Dioxide‐Polymer‐Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways
Advanced Science·2023· 31 citedOpen Access
Biocompatible and Bioactivable Mno2 Nanoparticle-Based MRI Contrast Agent for Improving Tumor Detection and Delineation
SSRN Electronic Journal·2023Open Access
Improving Vascular Functions by Bioreactive Nanoparticles for Treatment of Alzheimer’s Disease
Alzheimer s & Dementia·2022
Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs
Molecular Pharmaceutics·2022· 13 cited

Frequent Co-authors

Jeffrey T. Henderson(11), Xiao Yu Wu(10), Andrew M. Rauth(9), Chunsheng He(8), Azhar Z. Abbasi(8), Paul E. Fraser(7), Lily Yi Li(5), Warren D. Foltz(4), HoYin Lip(4), Taksim Ahmed(3), Shudi Huang(3), Tin-Yo C. Yen(2), Mohammad Amini(2), Hibret A. Adissu(2), Ibrahim Alradwan(2), Abdulmottaleb Zetrini(2), Meng Tian(2), Li‐Ting Wang(2), John Georgiou(2), Graham L. Collingridge(2)